The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
Open accessAbstract
The use of nanoparticles (NP) in diagnosis and treatment of many human diseases, including cancer, is of increasing interest. However, cytotoxic effects of NPs on cells and the uptake efficiency significantly limit their use in clinical practice. The physico-chemical properties of NPs including surface composition, superficial charge, size and shape are considered the key factors that affect the biocompatibility and uptake efficiency of these nanoplatforms. Thanks to the possibility of modifying physico-chemical properties of NPs, it is possible to improve their biocompatibility and uptake efficiency through the functionalization of the NP surface. In this review, we summarize some of the most recent studies in which NP surface modification enhances biocompatibility and uptake. Furthermore, the most used techniques used to assess biocompatibility and uptake are also reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Bhargava, K., Arya, A., Gangwar, A., Singh, S. K., Roy, M., Das, M., & Sethy, N. K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s102096 · Cited by 79
RetractedDevelopment of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer
Li, C., Cai, G., Song, D., Gao, R., Teng, P., Zhou, L., Ji, Q., Sui, H. X., Cai, J., Li, Q., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00613c · Cited by 69
RetractedMechanism of cell death induced by silica nanoparticles in hepatocyte cells is by apoptosis
Yang, Y., Du, X., Wang, Q., Liu, J., Zhang, E., Sai, L., Peng, C., Lavin, M. F., Yeo, A. J., Yang, X., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4265 · Cited by 68
RetractedReview on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.98 · Cited by 3,297
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
Karlsson, H. L., Cronholm, P., Gustafsson, J., & Möller, L. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800064j · Cited by 1,480
Schirrmacher, V. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4661 · Cited by 1,296
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179 · cited 1×
“This phenomenon, known as the enhanced permeability retention (EPR) effect, permits the passive accumulation of NPs to solid tumors and/or metastatic sites, simply through their particular physical properties including size, shape, and superficial charge (Maeda, 2015).”
BackgroundParameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Cited by
Scale-up polymeric-based nanoparticles drug delivery systems: Development and challenges
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · OpenNano · doi:10.1016/j.onano.2022.100048 · Cited by 329
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 294
Tiwari, P., Yadav, K., Shukla, R. P., Gautam, S., Marwaha, D., Sharma, M., & Mishra, P. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.016 · Cited by 88
Han, B., Zhang, R., Li, L., Hu, C., Li, M., Liu, J., Sun, X., Fan, W., Xie, J., & Lei, Y. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01430d · Cited by 11
Tao, J., Ning, W., Lu, W., Wang, R., Zhou, H., Zhang, H., Xu, J., Wang, S., Teng, Z., & Wang, L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.058 · Cited by 10
Hybrid Multifunctional Nanomaterials for Diagnostic and Therapeutic Applications
Lagopati, N., Efstathopoulos, E. P., Veroutis, D., Katifelis, H., Theocharous, G., Pantelis, P., Evangelou, K., Gorgoulis, V. G., & Gazouli, M. (2022) · Nanotechnology in the Life Sciences · doi:10.1007/978-3-031-12658-1_17 · Cited by 6
Metadata
- Authors
- Sanità, G., Carrese, B., & Lamberti, A.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2020-11-26
- Volume
- 7
- Pages
- 587012-587012
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W3108799745
- Cited by
- 765
- References
- 189
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.